# Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.

> **NCT05586763** · PHASE3 · RECRUITING · sponsor: **Oman Medical Speciality Board** · enrollment: 90 (estimated)

## Conditions studied

- Peripheral Vertigo

## Interventions

- **DRUG:** Metoclopramid ( 10mg), IM promethazine (25mg) , IM prochloroperazine( 12.5mg)

## Key facts

- **NCT ID:** NCT05586763
- **Lead sponsor:** Oman Medical Speciality Board
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2024-12-28
- **Final completion:** 2024-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586763, "Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05586763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*